Gene Polymorphisms in Detoxification Enzymes as Susceptibility Factor for Head and Neck Cancer?

Abstract

OBJECTIVE: Impaired detoxification of carcinogens found in tobacco smoke appears to increase the risk for tobacco associated cancer. The objective of this study was to investigate concomitant polymorphisms in genes encoding for various detoxification enzymes in patients with head and neck squamous cell carcinoma (HNSCC).

METHODS: In 187 patients with HNSCC and in 139 healthy control subjects, the polymorphisms of cytochrome P450 1A1 (CYP1A1), cytochrome P450 2D6 (CYP2D6), and glutathione S-transferase μ1 and θ (GSTM1, GSTT1) were detected by polymerase chain reaction.

RESULTS: No significant association were identified between CYP1A1 and CYP2D6 gene polymorphisms and HNSCC. Patients with laryngeal cancer revealed the GSTM1 null genotype more frequently than did the control subjects (P < 0.05). The coincidence of GSTM1 and GSTT1 null genotype was found twice as great in patients as in control subjects (P < 0.05).

CONCLUSIONS: It is assumed that detoxification enzymes are functionally redundant and only the simultaneous deficiency of several detoxification enzymes increase the risk for HNSCC in alcohol- and tobacco-exposed individuals.

Get full access to this article

View all access options for this article.

References

Bale

Nebert

McBride

Subchromosomal localisation of the dioxin-inducible P-450 locus (CYP1) and description of two RFLPs detected with a 3′ P-450 cDNA probe. Cytogenet Cell Genet 1987;46:574–5.

Nakachi

Imai

Hayashi

Genetic susceptibility to squamous cell carcinoma of the lung in relation to cigarette smoking dose. Cancer Res 1991;51:5177–80.

Rannung

Alexandrie

Persson

Genetic polymorphism of cytochromes 1A1, 2D6 and 2E1: regulation and toxicological significance. J Occup Environ Med 1995;37:25–36.

Anwar

Abdel-Rahman

El-Zein

Genetic polymorphism of GSTM1, CYP2E1 and CYP2D6 in Egyptian bladder cancer patients. Carcinogenesis 1996;17:1923–9.

Roots

Drakoulis

Brockmoller

Polymorphic enzymes and cancer risk: concepts, methodology and data review. In: Kalow

, editor. Pharmacogenetics of Drug Metabolism. New York: Pergamon Presse; 1992. p. 815–41.

Hayes

Pulford

DJ.

The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol 1995;30:445–600.

Board

Biochemical genetics of glutathione S-transferase in man. Am J Hum Genet 1981;33:36–43.

Pemble

Schroeder

Spencer

Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterisation of a genetic polymorphism. Biochem J 1994;300:267–71.

Tang

Rundle

Warburton

Association between both genetic and environmental biomarkers and lung cancer: evidence of a great risk of lung cancer in women smoker. Carcinogenesis 1998;19:1949–53.

10.

Ford

O'Sullivan

Glutathione S-transferase M1 polymorphism and lung cancer risk in African-Americans. Carcinogenesis 2000;21:1971–5.

11.

Sato

Izumo

Genetic polymorphism of drug-metabolizing enzymes and susceptibility to oral cancer. Carcinogenesis 1999;20:1927–31.

12.

Oude Ophius

van Lieshout

Roelofs

Glutathione S-transferase M1 and T1 and cytochrome P4501A1 polymorphism in relation to the risk for benign and malignant head and neck lesions. Cancer 1999;82:936–43.

13.

Saarikoski

Sata

Husgafvel-Pursiainen

CYP2D6 ultrarapid metabolizer genotype as a potential modifier of smoking behaviour. Pharmacogenetics 2000;10:5–10.

14.

Boustead

Taber

Idle

CYP2D6 genotype and smoking behaviour in cigarette smokers. Pharmacogenetics 1997;7:411–4.

15.

Cheng

Sturgis

Eicher

Glutathione S-transferase polymorphisms and risk of squamous cell carcinoma of head and neck. Int J Cancer 1999;84:220–4.

16.

Madhusudan

Prasann

Kamala

Human leucocyte glutathion S-transferase isoenzyme (class mu) and susceptibility to smoking-related cancers. J Toxicol Environ Health 1995;46:1–8.

17.

Smith

Stanley

Sim

Metabolic polymorphisms and cancer susceptibility. Cancer Surv 1995;25:27–75.

18.

Drakoulis

Cascorbi

Brockmöller

Polymorphisms in human lung cancer: exon 7 mutation (4889 A to G) and a T to C mutation in the 3′-flanking region. Clin Invest 1994;72:240–8.

19.

Bennett

Alavanja

MCR

Blomeke

Environmental tobacco smoke, genetic susceptibility and risk of lung cancer in never smoking women. J Natl Cancer Inst 1999;91:2009–14.

20.

Cascorbi

Brockmoller

Roots

A C4887A polymorphism in exon 7 of human CYP1A1: population frequency, mutation linkages and impact on lung cancer susceptibility. Cancer Res 1996;56:4965–9.